Liver allograft pathology in healthy pediatric liver transplant recipients

Area of Science:

• Pediatric Gastroenterology
• Transplant Surgery
• Immunology

Background:

• Liver transplantation is a life-saving procedure for pediatric end-stage liver disease.
• Maintaining long-term graft health is crucial for successful outcomes.
• Low-maintenance immunosuppression is often used in pediatric liver transplant recipients.

Purpose of the Study:

• To evaluate the utility of protocol liver biopsies in healthy pediatric liver transplant recipients on low-dose immunosuppression.
• To assess if protocol biopsies help adapt immunosuppression and protect long-term graft function.
• To correlate histological findings with laboratory, serological, and radiological results.

Main Methods:

• Sixty healthy pediatric liver transplant recipients underwent protocol liver biopsies.
• Histological findings were analyzed and correlated with clinical data.
• Immunosuppressive medication adjustments were made based on biopsy results.

Main Results:

• Twenty-three percent of patients showed acute or early chronic rejection.
• Thirty-six percent of long-term recipients (≥5 years) had fibrosis.
• Liver function tests did not correlate with histological findings of rejection or fibrosis.
• A high prevalence of rejection and fibrosis was observed in asymptomatic children.

Conclusions:

• Scheduled liver biopsies are valuable for early detection of morphological changes in pediatric liver transplants, even in asymptomatic patients on low immunosuppression.
• Protocol biopsies prompted changes in immunosuppressive therapy for a significant number of children.
• Further research is needed to confirm if adapting immunosuppression based on biopsies reduces long-term tissue damage and allograft dysfunction.